Posted on Sep 28, 2018
Drugmakers Play The Patent Game To Lock In Prices, Block Competitors
865
0
1
0
0
0
Patent No. 9861628 is for a fast-dissolving wafer containing buprenorphine, a generic drug that has been around since the 1970s. Herzberg, a historian who focuses on the opioid epidemic and the history of prescription drugs, said he fears the patent could keep prices high and make it more difficult for poor addicts to get treatment. "It's hard not to have that reaction of, like ... these vultures," said Herzberg, an associate professor at the University of Buffalo.
Drugmakers Play The Patent Game To Lock In Prices, Block Competitors
Posted from npr.orgPosted in these groups: 
Drugs
Pharmaceuticals
Substance Use
University at BuffaloUnited States Patent and Trademark Office
Drugs Pharmaceuticals Substance Use University at BuffaloUnited States Patent and Trademark Office
Posted 6 y ago
Responses: 1
0
0
0
Playing Devil's advocate, the original patent holder took the time and money to develop the drug and make sure it was relatively safe, clinical trials and stuff. Now someone else wants to make big money on the product with out an investment into development. Were I the patent holder I'd be fighting for my right to keep my cash cow also.
(0)
(0)
Read This Next
Continue with Facebook 
Continue with Google